iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Gladstone Institutional Advisory LLC

Gladstone Institutional Advisory LLC lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 11.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,871 shares of the financial services provider’s stock after selling 520 shares during the period. Gladstone Institutional Advisory LLC’s holdings in iShares Biotechnology ETF were worth $512,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of IBB. BNP Paribas Financial Markets boosted its stake in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $18,476,000. DRW Securities LLC purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $5,990,000. Finally, Erste Asset Management GmbH acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at approximately $5,678,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $136.55 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The stock’s fifty day moving average is $135.73 and its two-hundred day moving average is $141.03.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.